サマリー

腫瘍アブレーションとは、がん細胞を破壊するための一般的な用語です。インターベンショナル・アブレーションは、肝臓がん、腎臓がん、肺がんを対象とした画像誘導型の治療法で、高熱（高周波、マイクロ波）や冷熱（凍結融解）を直接当てて腫瘍細胞を破壊します。外科的に切除できない小さな腎臓がんや肝臓がんに最も適しています。実際、小さな腎臓がんに対する高周波や冷凍アブレーションは、大規模な手術と同等の効果があることがわかっています。

市場分析と洞察。インターベンショナルオンコロジーアブレーションデバイスの世界市場
2021年のインターベンショナルオンコロジーアブレーションデバイスの世界市場規模は百万米ドルで、2021-2027年の間に年率％で推移し、2027年末には百万米ドルに達すると予想されています。
業界標準の正確な分析と高いデータ整合性を備えた本レポートは、世界のインターベンショナル・オンコロジー・アブレーション装置市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つ見事な試みを行っています。本レポートの購入者は、検証された信頼性の高い市場予測にアクセスすることができ、その中には、収益面での世界のインターベンショナル・オンコロジー・アブレーション装置市場全体のサイズも含まれています。
本レポートは、プレイヤーが競合他社に対して優位に立ち、世界のInterventional Oncology Ablation Device市場で永続的な成功を収めるための有効なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界のInterventional Oncology Ablation Device市場を詳細に調査するために、独自の、そして業界で最も優れた調査・分析手法を用いています。

世界のインターベンショナルオンコロジーアブレーション装置の範囲と市場規模
インターベンショナルオンコロジーアブレーションデバイス市場は、企業別、地域（国）別、タイプ別、アプリケーション別に分類されています。世界のインターベンショナルオンコロジーアブレーションデバイス市場のプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間で、タイプ別とアプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
ラジオ波アブレーション
マイクロ波アブレーション
クライオアブレーション
その他

用途別セグメント
肝臓がん
肺がん
腎臓がん
その他

地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
U.K.
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
ボストン・サイエンティフィック
メドトロニック
ジョンソン・エンド・ジョンソン
メリットメディカル
バリアンメディカル
アンジオダイナミクス（AngioDynamics
ヘルトロニクス
EDAP TMS
ソナケア・メディカル
ミソニックス
CAScination AG
バイオメディカルSrl
重慶Haifuメディカル

ページTOPに戻る

目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Interventional Oncology Ablation Device Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Radiofrequency Ablation
1.2.3 Microwave Ablation
1.2.4 Cryoablation
1.2.5 Other
1.3 Market by Application
1.3.1 Global Interventional Oncology Ablation Device Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Liver Cancer
1.3.3 Lung Cancer
1.3.4 Kidney Cancer
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Interventional Oncology Ablation Device Market Perspective (2016-2027)
2.2 Interventional Oncology Ablation Device Growth Trends by Regions
2.2.1 Interventional Oncology Ablation Device Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Interventional Oncology Ablation Device Historic Market Share by Regions (2016-2021)
2.2.3 Interventional Oncology Ablation Device Forecasted Market Size by Regions (2022-2027)
2.3 Interventional Oncology Ablation Device Industry Dynamic
2.3.1 Interventional Oncology Ablation Device Market Trends
2.3.2 Interventional Oncology Ablation Device Market Drivers
2.3.3 Interventional Oncology Ablation Device Market Challenges
2.3.4 Interventional Oncology Ablation Device Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Interventional Oncology Ablation Device Players by Revenue
3.1.1 Global Top Interventional Oncology Ablation Device Players by Revenue (2016-2021)
3.1.2 Global Interventional Oncology Ablation Device Revenue Market Share by Players (2016-2021)
3.2 Global Interventional Oncology Ablation Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Interventional Oncology Ablation Device Revenue
3.4 Global Interventional Oncology Ablation Device Market Concentration Ratio
3.4.1 Global Interventional Oncology Ablation Device Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Interventional Oncology Ablation Device Revenue in 2020
3.5 Interventional Oncology Ablation Device Key Players Head office and Area Served
3.6 Key Players Interventional Oncology Ablation Device Product Solution and Service
3.7 Date of Enter into Interventional Oncology Ablation Device Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Interventional Oncology Ablation Device Breakdown Data by Type
4.1 Global Interventional Oncology Ablation Device Historic Market Size by Type (2016-2021)
4.2 Global Interventional Oncology Ablation Device Forecasted Market Size by Type (2022-2027)

5 Interventional Oncology Ablation Device Breakdown Data by Application
5.1 Global Interventional Oncology Ablation Device Historic Market Size by Application (2016-2021)
5.2 Global Interventional Oncology Ablation Device Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Interventional Oncology Ablation Device Market Size (2016-2027)
6.2 North America Interventional Oncology Ablation Device Market Size by Type
6.2.1 North America Interventional Oncology Ablation Device Market Size by Type (2016-2021)
6.2.2 North America Interventional Oncology Ablation Device Market Size by Type (2022-2027)
6.2.3 North America Interventional Oncology Ablation Device Market Size by Type (2016-2027)
6.3 North America Interventional Oncology Ablation Device Market Size by Application
6.3.1 North America Interventional Oncology Ablation Device Market Size by Application (2016-2021)
6.3.2 North America Interventional Oncology Ablation Device Market Size by Application (2022-2027)
6.3.3 North America Interventional Oncology Ablation Device Market Size by Application (2016-2027)
6.4 North America Interventional Oncology Ablation Device Market Size by Country
6.4.1 North America Interventional Oncology Ablation Device Market Size by Country (2016-2021)
6.4.2 North America Interventional Oncology Ablation Device Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Interventional Oncology Ablation Device Market Size (2016-2027)
7.2 Europe Interventional Oncology Ablation Device Market Size by Type
7.2.1 Europe Interventional Oncology Ablation Device Market Size by Type (2016-2021)
7.2.2 Europe Interventional Oncology Ablation Device Market Size by Type (2022-2027)
7.2.3 Europe Interventional Oncology Ablation Device Market Size by Type (2016-2027)
7.3 Europe Interventional Oncology Ablation Device Market Size by Application
7.3.1 Europe Interventional Oncology Ablation Device Market Size by Application (2016-2021)
7.3.2 Europe Interventional Oncology Ablation Device Market Size by Application (2022-2027)
7.3.3 Europe Interventional Oncology Ablation Device Market Size by Application (2016-2027)
7.4 Europe Interventional Oncology Ablation Device Market Size by Country
7.4.1 Europe Interventional Oncology Ablation Device Market Size by Country (2016-2021)
7.4.2 Europe Interventional Oncology Ablation Device Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Interventional Oncology Ablation Device Market Size (2016-2027)
8.2 Asia-Pacific Interventional Oncology Ablation Device Market Size by Type
8.2.1 Asia-Pacific Interventional Oncology Ablation Device Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Interventional Oncology Ablation Device Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Interventional Oncology Ablation Device Market Size by Type (2016-2027)
8.3 Asia-Pacific Interventional Oncology Ablation Device Market Size by Application
8.3.1 Asia-Pacific Interventional Oncology Ablation Device Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Interventional Oncology Ablation Device Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Interventional Oncology Ablation Device Market Size by Application (2016-2027)
8.4 Asia-Pacific Interventional Oncology Ablation Device Market Size by Region
8.4.1 Asia-Pacific Interventional Oncology Ablation Device Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Interventional Oncology Ablation Device Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Interventional Oncology Ablation Device Market Size (2016-2027)
9.2 Latin America Interventional Oncology Ablation Device Market Size by Type
9.2.1 Latin America Interventional Oncology Ablation Device Market Size by Type (2016-2021)
9.2.2 Latin America Interventional Oncology Ablation Device Market Size by Type (2022-2027)
9.2.3 Latin America Interventional Oncology Ablation Device Market Size by Type (2016-2027)
9.3 Latin America Interventional Oncology Ablation Device Market Size by Application
9.3.1 Latin America Interventional Oncology Ablation Device Market Size by Application (2016-2021)
9.3.2 Latin America Interventional Oncology Ablation Device Market Size by Application (2022-2027)
9.3.3 Latin America Interventional Oncology Ablation Device Market Size by Application (2016-2027)
9.4 Latin America Interventional Oncology Ablation Device Market Size by Country
9.4.1 Latin America Interventional Oncology Ablation Device Market Size by Country (2016-2021)
9.4.2 Latin America Interventional Oncology Ablation Device Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Interventional Oncology Ablation Device Market Size (2016-2027)
10.2 Middle East & Africa Interventional Oncology Ablation Device Market Size by Type
10.2.1 Middle East & Africa Interventional Oncology Ablation Device Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Interventional Oncology Ablation Device Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Interventional Oncology Ablation Device Market Size by Type (2016-2027)
10.3 Middle East & Africa Interventional Oncology Ablation Device Market Size by Application
10.3.1 Middle East & Africa Interventional Oncology Ablation Device Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Interventional Oncology Ablation Device Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Interventional Oncology Ablation Device Market Size by Application (2016-2027)
10.4 Middle East & Africa Interventional Oncology Ablation Device Market Size by Country
10.4.1 Middle East & Africa Interventional Oncology Ablation Device Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Interventional Oncology Ablation Device Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Boston Scientific
11.1.1 Boston Scientific Company Details
11.1.2 Boston Scientific Business Overview
11.1.3 Boston Scientific Interventional Oncology Ablation Device Introduction
11.1.4 Boston Scientific Revenue in Interventional Oncology Ablation Device Business (2016-2021)
11.1.5 Boston Scientific Recent Development
11.2 Medtronic
11.2.1 Medtronic Company Details
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Interventional Oncology Ablation Device Introduction
11.2.4 Medtronic Revenue in Interventional Oncology Ablation Device Business (2016-2021)
11.2.5 Medtronic Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Interventional Oncology Ablation Device Introduction
11.3.4 Johnson & Johnson Revenue in Interventional Oncology Ablation Device Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Merit Medical
11.4.1 Merit Medical Company Details
11.4.2 Merit Medical Business Overview
11.4.3 Merit Medical Interventional Oncology Ablation Device Introduction
11.4.4 Merit Medical Revenue in Interventional Oncology Ablation Device Business (2016-2021)
11.4.5 Merit Medical Recent Development
11.5 Varian Medical
11.5.1 Varian Medical Company Details
11.5.2 Varian Medical Business Overview
11.5.3 Varian Medical Interventional Oncology Ablation Device Introduction
11.5.4 Varian Medical Revenue in Interventional Oncology Ablation Device Business (2016-2021)
11.5.5 Varian Medical Recent Development
11.6 AngioDynamics
11.6.1 AngioDynamics Company Details
11.6.2 AngioDynamics Business Overview
11.6.3 AngioDynamics Interventional Oncology Ablation Device Introduction
11.6.4 AngioDynamics Revenue in Interventional Oncology Ablation Device Business (2016-2021)
11.6.5 AngioDynamics Recent Development
11.7 HealthTronics
11.7.1 HealthTronics Company Details
11.7.2 HealthTronics Business Overview
11.7.3 HealthTronics Interventional Oncology Ablation Device Introduction
11.7.4 HealthTronics Revenue in Interventional Oncology Ablation Device Business (2016-2021)
11.7.5 HealthTronics Recent Development
11.8 EDAP TMS
11.8.1 EDAP TMS Company Details
11.8.2 EDAP TMS Business Overview
11.8.3 EDAP TMS Interventional Oncology Ablation Device Introduction
11.8.4 EDAP TMS Revenue in Interventional Oncology Ablation Device Business (2016-2021)
11.8.5 EDAP TMS Recent Development
11.9 SonaCare Medical
11.9.1 SonaCare Medical Company Details
11.9.2 SonaCare Medical Business Overview
11.9.3 SonaCare Medical Interventional Oncology Ablation Device Introduction
11.9.4 SonaCare Medical Revenue in Interventional Oncology Ablation Device Business (2016-2021)
11.9.5 SonaCare Medical Recent Development
11.10 Misonix
11.10.1 Misonix Company Details
11.10.2 Misonix Business Overview
11.10.3 Misonix Interventional Oncology Ablation Device Introduction
11.10.4 Misonix Revenue in Interventional Oncology Ablation Device Business (2016-2021)
11.10.5 Misonix Recent Development
11.11 CAScination AG
11.11.1 CAScination AG Company Details
11.11.2 CAScination AG Business Overview
11.11.3 CAScination AG Interventional Oncology Ablation Device Introduction
11.11.4 CAScination AG Revenue in Interventional Oncology Ablation Device Business (2016-2021)
11.11.5 CAScination AG Recent Development
11.12 Biomedical Srl
11.12.1 Biomedical Srl Company Details
11.12.2 Biomedical Srl Business Overview
11.12.3 Biomedical Srl Interventional Oncology Ablation Device Introduction
11.12.4 Biomedical Srl Revenue in Interventional Oncology Ablation Device Business (2016-2021)
11.12.5 Biomedical Srl Recent Development
11.13 Chongqing Haifu Medical
11.13.1 Chongqing Haifu Medical Company Details
11.13.2 Chongqing Haifu Medical Business Overview
11.13.3 Chongqing Haifu Medical Interventional Oncology Ablation Device Introduction
11.13.4 Chongqing Haifu Medical Revenue in Interventional Oncology Ablation Device Business (2016-2021)
11.13.5 Chongqing Haifu Medical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details